Free Trial

LPL Financial LLC Buys 12,033 Shares of Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background
Remove Ads

LPL Financial LLC grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 31.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,342 shares of the company's stock after acquiring an additional 12,033 shares during the quarter. LPL Financial LLC owned about 0.11% of Azenta worth $2,590,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of AZTA. Picton Mahoney Asset Management boosted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares in the last quarter. KBC Group NV boosted its stake in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Azenta during the fourth quarter valued at approximately $200,000. Catalyst Funds Management Pty Ltd lifted its holdings in shares of Azenta by 123.0% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 4,684 shares of the company's stock worth $234,000 after acquiring an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC bought a new stake in shares of Azenta in the 4th quarter worth approximately $293,000. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AZTA. Needham & Company LLC lifted their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Evercore ISI boosted their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Stephens restated an "overweight" rating and set a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd. Finally, TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th.

Remove Ads

View Our Latest Report on Azenta

Azenta Trading Down 6.2 %

NASDAQ AZTA traded down $1.71 on Tuesday, hitting $25.91. The company's stock had a trading volume of 788,200 shares, compared to its average volume of 634,823. Azenta, Inc. has a 52-week low of $25.36 and a 52-week high of $63.58. The firm has a market cap of $1.18 billion, a P/E ratio of -8.69 and a beta of 1.66. The company's 50-day simple moving average is $38.34 and its 200 day simple moving average is $44.44.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

About Azenta

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads